Kabra Drugs Ltd.
Fundamentals
- Market cap
- ₹57.68 cr
- P/E
- 11.63×
- ROE
- 0.00%
- Debt / equity
- 0.02
- 52-week range
- 13.46 — 35.52
Company snapshot
Kabra Drugs Ltd.
Pharmaceuticals
₹58 cr
P/E 11.63×
Latest quarter · Mar 2026
Sales₹35 cr
Net profit₹1 cr
Op. margin+3.8%
EPS₹0.45
Strength & growth
Debt / equity0.02×
Current ratio43.84×
Sales CAGR+25.4%
EPS CAGR+49.3%
The timeline — 3 notes on Kabra Drugs Ltd.
May 2026
- 29 May 26 · 10:21 PM IST Brief Brief · Earnings · Micro cap
Kabra Drugs goes from zero revenue to ₹92.74 cr in one year
The nano-cap swung to a ₹4.96 cr profit after a ₹1.08 cr loss last year. A new manufacturing strategy delivered ₹35 cr in the final quarter alone.
- 29 May 26 · 8:35 PM IST Brief Brief · Earnings · Micro cap
Kabra Drugs' revenue jumped from zero to ₹92.74 cr in a single year
The nano-cap's new manufacturing strategy swung it from a ₹1.08 cr loss to a ₹4.96 cr profit. The numbers are audited.